IVD Contract Manufacturing Services Market Projections 2025-2030: Key Trends, Opportunities, and Growth Factors in New Report

IVD Contract Manufacturing Services Market Overview:

The global IVD contract manufacturing services market is projected to grow at a CAGR of roughly 11% over the forecast period. This expansion is driven by several factors, including increasing demand for point-of-care (PoC) testing, government initiatives to scale up IVD kit production post-COVID-19, rising incidence of cancer and infectious diseases, and the benefits offered by IVD contract manufacturers—such as cost efficiency, scalability, technical expertise, and risk mitigation.

Download Sample Copy: https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

In-vitro diagnostics (IVD) involve testing samples such as blood or tissue to detect diseases or other conditions and to monitor overall health for prevention, diagnosis, or treatment. OEMs are increasingly outsourcing to IVD contract development and manufacturing organizations (CDMOs) to leverage their cost advantages, specialized know-how, scalable operations, and ability to reduce regulatory and supply-chain risks.

Competitive Landscape Analysis

The IVD Contract Manufacturing Services market is marked by the presence of key players such as Jabil Inc., STRATEC, Celestica, Sanmina Corporation, Röchling, KMC Systems, Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Thermo Fisher Scientific Inc., Cenogenics Corporation, Coris BioConcept, Gerresheimer, and Phillips-Medisize, among others. Some of the key strategies adopted by market players include strategic partnerships and collaborations and geographic expansion.

Rising preference for point-of-care testing accelerates market growth

As healthcare systems aim to shorten turnaround times and empower patients with faster, more accessible results, demand for PoC diagnostics continues to rise. PoC testing—delivered in hospitals, clinics, physicians’ offices, or even at home—requires devices with high-precision components, fluid handling, and reagent processing. These complex manufacturing needs make specialized IVD CDMOs essential partners for OEMs.

“Rising demand for point-of-care IVD devices is a key driver for growth. Recently launched PoC instruments are convenient and efficient, but their design and production present challenges that IVD CDMOs are uniquely positioned to solve.”
— Director, Leading IVD OEM, United States

Cost savings, scalability, technical expertise, and risk reduction boost reliance on IVD CDMOs

By collaborating with IVD contract manufacturers, OEMs reduce labor and automation costs and benefit from economies of scale. CDMOs also offer advanced technical capabilities that many OEMs do not possess in-house. Additionally, outsourcing helps mitigate regulatory and supply-chain risks. Recent partnerships highlight this trend:

• January 2025: Akoya Biosciences selected Argonaut Manufacturing Services to support production of IVD products, accelerating commercialization and expanding Akoya’s IVD portfolio.
• March 2024: Beckman Coulter and Fujirebio partnered to co-develop patient-friendly, blood-based Alzheimer’s tests, utilizing Fujirebio’s IVD expertise and manufacturing capabilities.

Download Sample Copy: https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

Growing burden of cancer and infectious diseases strengthens demand

IVDs are central to cancer screening, diagnosis, and treatment decisions, providing insights into disease risk, stage, and treatment response. They are equally critical in infectious disease management—measuring analyte concentrations, detecting specific biomarkers, and guiding timely treatment decisions. As cases of cancer and infectious diseases continue to rise globally, the need for reliable, high-quality diagnostic manufacturing is expected to intensify, further driving demand for IVD contract manufacturing services.

Global IVD Contract Manufacturing Services Market Segmentation

This report by Medi-Tech Insights provides the size of the global IVD contract manufacturing services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service, technology, and end-user.

Market Size & Forecast (2023-2030), By Service, USD Million

• Manufacturing Services
• Assay Development Services
• Others

Market Size & Forecast (2023-2030), By Technology, USD Million

• Immunoassays
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation
• Others

Market Size & Forecast (2023-2030), By End-user, USD Million

• Medical Device Companies
• Academic & Research Institutes
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Browse Report: https://meditechinsights.com/ivd-contract-manufacturing-services-market/

About Medi-Tech Insights;

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com